ArticleJournal of cancer research and clinical oncology2026
Correction: Safety and efficacy of nab-paclitaxel combined with nedaplatin and bevacizumab in patients with platinum-resistant epithelial ovarian cancer: a retrospective cohort study.
Sijian Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.